Business
Press Release Jan 20 2025
Strides Pharma Science Limited has informed the Exchange regarding a press release dated January 20, 2025, titled "Strides receives USFDA approval for Acetaminophen and Ibuprofen Tablets, 125 mg /250 mg, Expanding the Existing OTC Portfolio.".
About this update from Strides Pharma Science Ltd
Strides Pharma Science Limited has informed the Exchange regarding a press release dated January 20, 2025, titled "Strides receives USFDA approval for Acetaminophen and Ibuprofen Tablets, 125 mg /250 mg, Expanding the Existing OTC Portfolio.". View Attachment
View stock analysis, news, and events for Strides Pharma Science Ltd